Toshiaki Yamazumi

In Vitro Activities of Ravuconazole (BMS-207147) against 541 Clinical Isolates of <i>Cryptococcus neoformans</i>

Toshiaki Yamazumi, Michael A. Pfaller, S. A. Messer et al. · Antimicrobial Agents and Chemotherapy · 2000 · 71 citations

Medicine, Microbiology, Pharmacology +14

Characterization of Heteroresistance to Fluconazole among Clinical Isolates of <i>Cryptococcus neoformans</i>

Toshiaki Yamazumi, Michael A. Pfaller, S. A. Messer et al. · Journal of Clinical Microbiology · 2003 · 61 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Comparison of the Vitek Gram-Positive Susceptibility 106 Card and the MRSA-Screen Latex Agglutination Test for Determining Oxacillin Resistance in Clinical Bloodstream Isolates of <i>Staphylococcus aureus</i>

Toshiaki Yamazumi, Steven A. Marshall, Werner W. Wilke et al. · Journal of Clinical Microbiology · 2001 · 59 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparison of the Vitek Gram-Positive Susceptibility 106 Card, the MRSA-Screen Latex Agglutination Test, and <i>mecA</i> Analysis for Detecting Oxacillin Resistance in a Geographically Diverse Collection of Clinical Isolates of Coagulase-Negative Staphylococci

Toshiaki Yamazumi, Itaru Furuta, Daniel J. Diekema et al. · Journal of Clinical Microbiology · 2001 · 35 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +16

Direct Detection of Methicillin Resistance in <i>Staphylococcus aureus</i> in Blood Culture Broth by Use of a Penicillin Binding Protein 2a Latex Agglutination Test

Qinfang Qian, Lata Venkataraman, James E. Kirby et al. · Journal of Clinical Microbiology · 2010 · 20 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17